Latest Lead News

Theta Gold Mines has mobilised contractors and begun civil works at its TGME Gold Mine Project, advancing steadily toward plant commissioning by the end of 2026 and production in early 2027.

Tigers Realm Coal's planned sale of its Russian subsidiaries faces ongoing delays due to regulatory hurdles and buyer demands for further price cuts, leaving the transaction in limbo and the company suspended from ASX trading.

Avecho Biotechnology has raised $2.5 million from institutional investors to fast-track manufacturing and regulatory preparations for its CBD TPM capsule amid ongoing Phase III trials.

Fortuna Metals is advancing exploration at its Mkanda and Kampini projects in Malawi, aiming to define a significant rutile resource by late 2026. Early drilling and sampling have revealed encouraging titanium mineralisation, positioning the company in a globally critical minerals hotspot.

Woodside Energy Group has sealed a strategic partnership with US infrastructure giant Williams, selling stakes in Louisiana LNG and Driftwood Pipeline for $378 million, accelerating the project’s path to first LNG in 2029.

Silex Systems announces that its exclusive licensee, Global Laser Enrichment, has achieved a critical technology milestone for its laser uranium enrichment process, enabling plans for a new US enrichment facility to advance.

Super Retail Group reports steady sales growth across its brands in the first 16 weeks of FY26, with Macpac leading the charge and a new loyalty program launched at Supercheap Auto.

Insignia Financial reported a 3.1% rise in Funds Under Management and Administration to $340.5 billion, driven by strong net inflows into its Wrap platform and strategic enhancements to its MLC offerings. The company also completed a key custody transition and unveiled a refreshed MLC brand campaign.

Brambles Limited reported robust FY25 financial results and sustainability achievements, highlighting a $1 billion free cash flow milestone and ambitious 2030 regenerative targets at its 2025 AGM.

Control Bionics has successfully raised $0.6 million through a shortfall placement, reinforcing investor confidence as it accelerates commercialisation of its neurotechnology in assistive communication and emerging sports markets.

Australian Clinical Labs has announced a 12-month on-market share buy-back program targeting up to 10% of its shares, aiming to enhance shareholder returns without compromising its financial strength.

Bellevue Gold Limited reported a robust September quarter with production and sales exceeding expectations, alongside a pioneering net zero emissions milestone. The company is well positioned for growth in FY26 with strategic leadership appointments and improved operational efficiencies.